Patents by Inventor Yu-Nong Gong

Yu-Nong Gong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11679102
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 28, 2021
    Date of Patent: June 20, 2023
    Assignee: Chang Gung University
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang
  • Publication number: 20220074939
    Abstract: A method for determining immune competence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) includes obtaining a blood sample from a subject in need thereof, detecting, in the blood sample, levels of binding antibodies against SARS-CoV-2 spike S1 protein and its receptor binding domain (RBD), and calculating a weighted value using a regression model. Another method for determining immune competence against SARS-CoV-2 is also disclosed.
    Type: Application
    Filed: September 9, 2021
    Publication date: March 10, 2022
    Inventors: Shin-Ru SHIH, Kuan-Ting LIU, Guang-Wu CHEN, Chung-Guei HUANG, Kar-Yee YU, Hou-Chen LEE, Peng-Nien HUANG, Yu-Nong GONG, Rei-Lin KUO, Chih-Ching WU, Yu-An KUNG, Sheng-Yu HUANG
  • Publication number: 20210386726
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of rosiglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with rosiglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG
  • Publication number: 20210386725
    Abstract: Disclosed herein is a method for inhibiting coronavirus infection, including administering to a subject in need thereof an effective amount of pioglitazone or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting coronavirus replication, including contacting a coronavirus with pioglitazone or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 16, 2021
    Inventors: Shin-Ru SHIH, Yu-An KUNG, Huan-Jung CHIANG, Chuan-Tien HUNG, Yu-Nong GONG, Hsin-Ping CHIU, Chiung-Guei HUANG, Peng-Nien HUANG, Sheng-Yu HUANG
  • Publication number: 20210386702
    Abstract: Disclosed herein is a method for inhibiting virus infection, including administering to a subject in need thereof an effective amount of a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof. Also disclosed is a method for inhibiting viral replication, including contacting a virus with a ferroptosis inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 28, 2021
    Publication date: December 16, 2021
    Inventors: Shin-Ru Shih, Yu-An Kung, Huan-Jung Chiang, Chuan-Tien Hung, Yu-Nong Gong, Hsin-Ping Chiu, Chiung-Guei Huang, Peng-Nien Huang, Sheng-Yu Huang